These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 2571638)
1. IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells. Holsti MA; Raulet DH J Immunol; 1989 Oct; 143(8):2514-9. PubMed ID: 2571638 [TBL] [Abstract][Full Text] [Related]
2. Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody. Holsti MA; McArthur J; Allison JP; Raulet DH J Immunol; 1994 Feb; 152(4):1618-28. PubMed ID: 7907103 [TBL] [Abstract][Full Text] [Related]
3. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. de Waal Malefyt R; Yssel H; de Vries JE J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412 [TBL] [Abstract][Full Text] [Related]
4. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking. Boyce NW; Jönsson JI; Emmrich F; Eichmann K J Immunol; 1988 Nov; 141(9):2882-8. PubMed ID: 3262671 [TBL] [Abstract][Full Text] [Related]
5. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes. Gangemi RM; Swack JA; Gaviria DM; Romain PL J Immunol; 1989 Oct; 143(8):2439-47. PubMed ID: 2794503 [TBL] [Abstract][Full Text] [Related]
6. Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains. Hoehn P; Goedert S; Germann T; Koelsch S; Jin S; Palm N; Ruede E; Schmitt E J Immunol; 1995 Oct; 155(8):3788-93. PubMed ID: 7561083 [TBL] [Abstract][Full Text] [Related]
7. Activation of Lyt-2+ (CD8+) and L3T4+ (CD4+) T cell subsets by anti-receptor antibody. Hathcock KS; Segal DM; Hodes RJ J Immunol; 1989 Apr; 142(7):2181-6. PubMed ID: 2784455 [TBL] [Abstract][Full Text] [Related]
8. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. Sepulveda H; Cerwenka A; Morgan T; Dutton RW J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007 [TBL] [Abstract][Full Text] [Related]
9. Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies. Goedert S; Germann T; Hoehn P; Koelsch S; Palm N; Rüde E; Schmitt E J Immunol; 1996 Jul; 157(2):566-73. PubMed ID: 8752903 [TBL] [Abstract][Full Text] [Related]
10. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse. Chen FL; Kung JT J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890 [TBL] [Abstract][Full Text] [Related]
11. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69. Woods M; Guy R; Waldmann H; Glennie M; Alexander DR Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688 [TBL] [Abstract][Full Text] [Related]
12. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation. Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy. Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624 [TBL] [Abstract][Full Text] [Related]
14. Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2. Baroja ML; Ceuppens JL; Van Damme J; Billiau A J Immunol; 1988 Sep; 141(5):1502-7. PubMed ID: 3261751 [TBL] [Abstract][Full Text] [Related]
15. Regulation of T cell proliferation by IL-7. Grabstein KH; Namen AE; Shanebeck K; Voice RF; Reed SG; Widmer MB J Immunol; 1990 Apr; 144(8):3015-20. PubMed ID: 1969881 [TBL] [Abstract][Full Text] [Related]
16. The differentiated state of intestinal lamina propria CD4+ T cells results in altered cytokine production, activation threshold, and costimulatory requirements. Hurst SD; Cooper CJ; Sitterding SM; Choi Jh; Jump RL; Levine AD; Barrett TA J Immunol; 1999 Dec; 163(11):5937-45. PubMed ID: 10570280 [TBL] [Abstract][Full Text] [Related]
17. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone. Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989 [TBL] [Abstract][Full Text] [Related]
18. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701 [TBL] [Abstract][Full Text] [Related]
19. Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies. Yang SY; Rhee S; Welte K; Dupont B J Immunol; 1988 Apr; 140(7):2115-20. PubMed ID: 3258328 [TBL] [Abstract][Full Text] [Related]
20. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. Croft M; Swain SL J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]